 Karin Pacheco
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 7 | 2024 | 341 | 2.030 |
Why?
| | Prostheses and Implants | 4 | 2024 | 143 | 1.950 |
Why?
| | Hypersensitivity | 6 | 2021 | 257 | 1.950 |
Why?
| | Allergens | 6 | 2024 | 409 | 1.760 |
Why?
| | Dermatitis, Allergic Contact | 3 | 2024 | 73 | 1.750 |
Why?
| | Nickel | 4 | 2021 | 62 | 1.350 |
Why?
| | Dermatitis, Occupational | 2 | 2020 | 14 | 1.240 |
Why?
| | Air Pollutants, Occupational | 2 | 2020 | 40 | 0.980 |
Why?
| | Arthroplasty, Replacement | 3 | 2021 | 45 | 0.970 |
Why?
| | Metals | 2 | 2024 | 136 | 0.930 |
Why?
| | Occupational Diseases | 3 | 2024 | 156 | 0.730 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.680 |
Why?
| | Isocyanates | 1 | 2020 | 9 | 0.680 |
Why?
| | Erythema | 1 | 2020 | 29 | 0.670 |
Why?
| | Trace Elements | 1 | 2020 | 51 | 0.650 |
Why?
| | HLA-DR Antigens | 1 | 2020 | 228 | 0.620 |
Why?
| | Host vs Graft Reaction | 1 | 2019 | 2 | 0.620 |
Why?
| | Dermatitis, Irritant | 1 | 2018 | 10 | 0.580 |
Why?
| | Patch Tests | 4 | 2021 | 57 | 0.550 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 153 | 0.430 |
Why?
| | Prosthesis Failure | 3 | 2021 | 123 | 0.400 |
Why?
| | Dental Offices | 1 | 2011 | 1 | 0.380 |
Why?
| | Leukocytes, Mononuclear | 2 | 2023 | 558 | 0.370 |
Why?
| | Asthma, Occupational | 1 | 2011 | 4 | 0.370 |
Why?
| | Irritants | 1 | 2011 | 43 | 0.360 |
Why?
| | Industry | 1 | 2011 | 68 | 0.350 |
Why?
| | Medical Laboratory Personnel | 1 | 2010 | 7 | 0.340 |
Why?
| | Bronchodilator Agents | 1 | 2011 | 252 | 0.320 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2010 | 85 | 0.320 |
Why?
| | Immunoglobulin E | 1 | 2011 | 342 | 0.320 |
Why?
| | Asthma | 3 | 2012 | 2295 | 0.320 |
Why?
| | Endotoxins | 1 | 2010 | 220 | 0.310 |
Why?
| | Epigenesis, Genetic | 1 | 2012 | 660 | 0.270 |
Why?
| | Polymorphism, Genetic | 1 | 2010 | 660 | 0.270 |
Why?
| | Sarcoidosis | 2 | 2024 | 159 | 0.230 |
Why?
| | Equipment and Supplies | 1 | 2024 | 42 | 0.220 |
Why?
| | Beryllium | 1 | 2024 | 153 | 0.210 |
Why?
| | Berylliosis | 1 | 2024 | 186 | 0.200 |
Why?
| | Humans | 17 | 2024 | 137585 | 0.190 |
Why?
| | Haptens | 1 | 2021 | 22 | 0.180 |
Why?
| | Joint Prosthesis | 1 | 2021 | 21 | 0.180 |
Why?
| | Bone Cements | 1 | 2021 | 43 | 0.170 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1431 | 0.150 |
Why?
| | T-Lymphocytes | 2 | 2021 | 1996 | 0.150 |
Why?
| | Gloves, Protective | 1 | 2018 | 2 | 0.150 |
Why?
| | Diagnosis, Differential | 2 | 2024 | 1483 | 0.150 |
Why?
| | Rubber | 1 | 2018 | 7 | 0.150 |
Why?
| | Flame Retardants | 1 | 2018 | 11 | 0.150 |
Why?
| | Cosmetics | 1 | 2018 | 9 | 0.150 |
Why?
| | Reoperation | 1 | 2021 | 573 | 0.140 |
Why?
| | Titanium | 1 | 2019 | 82 | 0.140 |
Why?
| | Disinfectants | 1 | 2018 | 39 | 0.140 |
Why?
| | Solvents | 1 | 2018 | 109 | 0.140 |
Why?
| | Avoidance Learning | 1 | 2018 | 76 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 189 | 0.140 |
Why?
| | Male | 10 | 2024 | 67762 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 718 | 0.130 |
Why?
| | Female | 10 | 2024 | 73304 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 364 | 0.120 |
Why?
| | Adult | 7 | 2024 | 37929 | 0.120 |
Why?
| | Epoxy Compounds | 1 | 2015 | 33 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1587 | 0.120 |
Why?
| | Methacrylates | 1 | 2015 | 117 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.110 |
Why?
| | Alleles | 2 | 2023 | 891 | 0.110 |
Why?
| | Hematologic Tests | 1 | 2013 | 22 | 0.100 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.100 |
Why?
| | Skin | 1 | 2018 | 752 | 0.100 |
Why?
| | Genotype | 2 | 2024 | 1916 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2019 | 657 | 0.090 |
Why?
| | Workers' Compensation | 1 | 2011 | 27 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 191 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1091 | 0.090 |
Why?
| | Aged | 4 | 2017 | 23961 | 0.090 |
Why?
| | Forced Expiratory Flow Rates | 1 | 2010 | 14 | 0.090 |
Why?
| | Young Adult | 2 | 2020 | 13209 | 0.080 |
Why?
| | Immunologic Factors | 1 | 2011 | 236 | 0.080 |
Why?
| | Workplace | 1 | 2011 | 261 | 0.080 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 261 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1946 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1142 | 0.070 |
Why?
| | Disease Management | 1 | 2011 | 628 | 0.070 |
Why?
| | Sequence Analysis, DNA | 2 | 2021 | 812 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2013 | 2475 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2013 | 4193 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3284 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2024 | 3556 | 0.060 |
Why?
| | HLA-DP beta-Chains | 1 | 2024 | 86 | 0.060 |
Why?
| | HLA-DR alpha-Chains | 1 | 2023 | 4 | 0.050 |
Why?
| | Mice | 2 | 2012 | 17787 | 0.050 |
Why?
| | HLA-DRB1 Chains | 1 | 2023 | 112 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2023 | 2426 | 0.050 |
Why?
| | VDJ Exons | 1 | 2021 | 2 | 0.040 |
Why?
| | Animals | 3 | 2017 | 36940 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7635 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 35 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 45 | 0.040 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 83 | 0.040 |
Why?
| | Exoribonucleases | 1 | 2019 | 49 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 137 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 313 | 0.040 |
Why?
| | DNA Helicases | 1 | 2019 | 145 | 0.040 |
Why?
| | Telomere-Binding Proteins | 1 | 2019 | 122 | 0.030 |
Why?
| | Insecta | 1 | 2017 | 67 | 0.030 |
Why?
| | Mucin-5B | 1 | 2019 | 224 | 0.030 |
Why?
| | Telomerase | 1 | 2019 | 250 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 539 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1250 | 0.030 |
Why?
| | Genetic Variation | 1 | 2019 | 991 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2074 | 0.030 |
Why?
| | RNA | 1 | 2019 | 921 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 21513 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5742 | 0.020 |
Why?
|
|
Pacheco's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|